Open Access

Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer

  • Authors:
    • Neshat Masud
    • Afaf Aldahish
    • Kenneth A. Iczkowski
    • Ajay Kale
    • Girish V. Shah
  • View Affiliations

  • Published online on: February 6, 2023     https://doi.org/10.3892/ijo.2023.5486
  • Article Number: 38
  • Copyright: © Masud et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostate‑derived calcitonin (CT) and its receptor induce tumorigenicity and increase metastatic potential of prostate cancer (PC). CT‑inducible genes in human prostate were identified by subtraction hybridization. Among these genes, zinc finger protein like 1 (ZFPL1) protein was interesting since it was abundantly expressed in malignant prostates but was almost absent in benign prostates. ZFPL1 expression was upregulated by CT and androgens, and ZFPL1 protein was secreted by prostate tumor cells through exosomal secretion. Serum levels of ZFPL1 in cancer patients were at least 4‑fold higher than those in the sera of cancer‑free individuals. Cell biology of ZFPL1 suggests its localization in Golgi bodies and exosomes, and its colocalization with chromogranin A and CD44. These results suggested that ZFPL1 is secreted by tumor cells of neuroendocrine (NE)/stem cell phenotype. The knockdown of endogenous ZFPL1 in (PC) cells led to a remarkable decrease in cell proliferation, and invasion while increasing their apoptosis. As expected, the overexpression of ZFPL1 in prostate cells had an opposite effect on these functions. The knockdown of ZFPL1 in PC cells also decreased Akt phosphorylation, suggesting the actions of ZFPL1 may be mediated through the PI3K‑Akt pathway. Moreover, the present results revealed that ZFPL1 is released by tumors cells of NE or androgen‑independent phenotype and its serum levels are significantly higher in cancer patients, suggesting that it may serve as a blood‑based non‑invasive biomarker of aggressive PC.
View Figures
View References

Related Articles

Journal Cover

March-2023
Volume 62 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Masud N, Aldahish A, Iczkowski KA, Kale A and Shah GV: Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer. Int J Oncol 62: 38, 2023
APA
Masud, N., Aldahish, A., Iczkowski, K.A., Kale, A., & Shah, G.V. (2023). Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer. International Journal of Oncology, 62, 38. https://doi.org/10.3892/ijo.2023.5486
MLA
Masud, N., Aldahish, A., Iczkowski, K. A., Kale, A., Shah, G. V."Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer". International Journal of Oncology 62.3 (2023): 38.
Chicago
Masud, N., Aldahish, A., Iczkowski, K. A., Kale, A., Shah, G. V."Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer". International Journal of Oncology 62, no. 3 (2023): 38. https://doi.org/10.3892/ijo.2023.5486